Press release
Pontine Glioma Drugs Market Research, Demand And Trend Analysis 2024-2033
Pontine Glioma Drugs Market Research
As per the report, the pontine glioma drugs market size has grown rapidly in recent years. It will grow from $0.88 billion in 2023 to $0.98 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The pontine glioma drugs market size is expected to see rapid growth in the next few years. It will grow to $1.50 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%.
Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15899&type=smp
Role of Personalized Medicine in Driving Growth Of The Pontine Glioma Drugs Market
The rise in demand for personalized medicine is expected to propel the growth of the pontine glioma drugs market going forward. Personalized medicine is an innovative approach that uses information about an individual's genomic, environmental, and lifestyle factors to guide decisions related to their medical management. The growing demand for personalized medicine is driven by its potential to provide more effective treatments, advancements in genomics, increasing disease complexity, and regulatory support. Personalized medicine significantly treats pontine gliomas by tailoring therapies to the specific genetic characteristics of the tumor and the individual patient. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the Food and Drug Administration (FDA) approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the rise in personalized medicine is driving the growth of the pontine glioma drugs market.
Innovative Small-Molecule Chemotherapeutics In The Pontine Glioma Drug Market
Major companies operating in the pontine glioma drugs market are focusing on developing innovative products, such as small-molecule chemotherapeutics, to maximize their revenues in the market. Small-molecule chemotherapeutics are drugs composed of relatively low molecular weight compounds that can effectively penetrate the blood-brain barrier to reach the site of the tumor in pontine glioma. For instance, in December 2022, Kintara Therapeutic, a US-based clinical-stage drug development company, received an orphan drug designation from the U.S. Food and Drug Administration (FDA) for a drug known as VAL-083. This drug is intended for the treatment of diffuse intrinsic pontine glioma (DIPG). VAL-083 is a first-in-class, small-molecule chemotherapeutic with a unique mechanism of action. It has shown clinical activity against various cancers, including the central nervous system, ovarian, and other solid tumors. This designation underscores the potential of VAL-083 as a treatment option for this challenging brain tumor, underscoring the commitment to addressing unmet medical needs in the treatment of DIPG.
The pontine glioma drugs market covered in this report is segmented -
1) By Type: Diffuse Brain Stem Glioma, Focal Brain Stem Glioma, Recurrent Brain Stem Glioma
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
3) By Application: Cancer Research Institutes, Diagnostic Laboratories, Hospitals
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15899&type=discount
Major companies operating in the pontine glioma drugs market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Teva Pharmaceutical Industries, Daiichi Sankyo Company Limited, The Menarini Group, Y-mAbs Therapeutics, Agios Pharmaceuticals, Kazia Therapeutic, DNAtrix Inc., Aminex Therapeutics Inc., Accendatech Co Ltd, Arog Pharmaceuticals, Kintara Therapeutics Inc., Medicenna Therapeutics, Alaunos Therapeutics, Biodexa Pharmaceuticals PLC
Contents of the report:
1. Executive Summary
2. Pontine Glioma Drugs Market Report Structure
3. Pontine Glioma Drugs Market Trends And Strategies
4. Pontine Glioma Drugs Market - Macro Economic Scenario
5. Pontine Glioma Drugs Market Size And Growth
…..
27. Pontine Glioma Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/pontine-glioma-drugs-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pontine Glioma Drugs Market Research, Demand And Trend Analysis 2024-2033 here
News-ID: 3582838 • Views: …
More Releases from The Business research company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Glioma
Glioma Market Growth Opportunities 2025-2034
Market Overview
The Glioma Market is witnessing steady growth as new therapeutic approaches continue to emerge for one of the most aggressive and complex forms of brain tumors. Gliomas originate in glial cells and represent the majority of malignant brain cancers. The increasing global incidence of glioblastoma and other high-grade gliomas, combined with rising awareness, improved diagnostic capability, and expanded research in precision oncology, is driving market demand. Novel immunotherapies, targeted…
Glioma Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Glioma Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the Glioma pipeline landscape. It covers the Glioma Pipeline Drug profiles, including clinical and nonclinical stage products. It also covers the Glioma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample and discover the recent advances…
Glioma Competitive Landscape 2023 (Updated)
DelveInsight's, "Glioma Competitive Landscape 2023" report provides comprehensive insights about 200+ Glioma companies and 220+ drugs in Glioma Competitive landscape. It covers the Glioma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Glioma Competitive Landscape Report
• DelveInsight's Glioma report depicts a robust space with 200+ Glioma companies working to develop 220+ pipeline therapies…
Low-Grade Glioma Therapeutics Market - Transforming Futures, Defying Low-Grade G …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Low-Grade Glioma Therapeutics Market.
Low-Grade Glioma Therapeutics Market: https://www.growthplusreports.com/report/lowgrade-glioma-therapeutics-market/9187
The Low-Grade Glioma Therapeutics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
Adult Malignant Glioma Therapeutics Market - Defying the Tumor, Empowering Survi …
Newark, New Castle, USA - new report, titled Adult Malignant Glioma Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Adult Malignant Glioma Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Adult Malignant Glioma Therapeutics market. The report offers…
Glioma pipeline involves 150+ key companies continuously working towards develop …
DelveInsight's, "Glioma Pipeline Insight, 2023," report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in Glioma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Glioma Pipeline Report
• DelveInsight's glioma pipeline report depicts a…
